# Kura Oncology: Biopharma, La Jolla, United States

> Kura Oncology: Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Source: https://millionrounds.com/startup/kura-oncology (Millionrounds; every figure on the page links to its filing or article)

United States · [Biopharma startup](https://millionrounds.com/companies)

# Kura Oncology

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Funding reported Last round: Post ipo equity

Biopharma La Jolla, United States

Company summary

- **Founded:** 2014 12 years old
- **Team:** 101 51 to 200 people
- **Funding reported:** $1.2B in dollars
- **Last round:** Post ipo equity Jan 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Kura Oncology has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Kura Oncology raised

Funding, as reported

Reported in all **$1.2B** in dollars

Rounds **12**

Last round **Post ipo equity**

Last round date **Jan 2024**

Investors listed **12**

SEC Form D **$242M sold, 2 filings, last Feb 2024**

## Founders and team

From Kura Oncology's own website and the SEC filings it signed: 13 on the team.

- **Jennifer Fulk** Chief Financial Officer
- **Brian Powl** Chief Commercial Officer
- **Kathleen Ford** Chief Operating Officer
- **Carol Schafer** September 21, 2022 / in Board of Directors
- **Diane Parks** September 21, 2022 / in Board of Directors
- **Faheem Hasnain** September 21, 2022 / in Board of Directors
- **Mary Szela** September 21, 2022 / in Board of Directors
- **Stephen Dale** Executive Officer i
- **Teresa Bair** Executive Officer i
- **Thomas Malley** September 21, 2022 / in Board of Directors
- **Troy Wilson** Executive Officer, Director i
- **Samir Vattompadam** Team
- **Tom Doyle** Team

On the board, as filed i *Helen Collins*

## On 4 portfolio pages

Investors who name them

- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners)
- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)
- [Nextech Invest](https://millionrounds.com/fund/nextech-invest)
- [Avoro Capital Advi...](https://millionrounds.com/fund/avoro-capital-advi)

Each firm lists Kura Oncology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in United States

Startups like it

- [**Altos Labs** San Francisco · founded 2021](https://millionrounds.com/startup/altos-labs)
- [**Vaxcyte** San Carlos · founded 2013](https://millionrounds.com/startup/vaxcyte)
- [**Madrigal Pharmaceuticals** Conshohocken · founded 2011](https://millionrounds.com/startup/madrigal-pharmaceuticals)
- [**Harmony Biosciences** Plymouth Meeting · founded 2017](https://millionrounds.com/startup/harmony-biosciences)
- [**Immunovant** New York · founded 2018](https://millionrounds.com/startup/immunovant)
- [**Solugen** Houston · founded 2016](https://millionrounds.com/startup/solugen-2)
- [**Dianthus Therapeutics** Waltham · founded 2019](https://millionrounds.com/startup/dianthus-therapeutics)
- [**Day One Biopharmaceuticals** South San Francisco · founded 2018](https://millionrounds.com/startup/day-one-biopharmaceuticals)

## Is this your company?

Add your raise, your deck and your story, and put Kura Oncology in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)